Assessment of Vancomycin Penetration into Cerebrospinal Fluid in Patients with Ventriculitis Using a Physiologically Based Pharmacokinetic Approach
Pharmaceutical Research · 2026
DOI: 10.1007/s11095-026-04023-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Larissa Martins Alves Guimarães und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacometrics (LabFarma), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-902, Brazil. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Cerebral Ventriculitis, Models, Biological. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal Do Rio De Janeiro.
Abstract (Originalsprache)
Introduction
Vancomycin is an antimicrobial agent for treating central nervous system (CNS) infections caused by Gram-positive bacteria. Due to practical and ethical reasons, it is difficult to evaluate vancomycin exposure in cerebrospinal fluid (CSF) and its relationship with therapeutic outcomes. Therefore, alternative methodologies are required. We developed a physiologically based pharmacokinetic (PBPK) model to characterize vancomycin exposure in plasma and CSF in patients with ventriculitis enrolled in a therapeutic drug monitoring program. Methodology PBPK modeling and simulation were conducted using PK-Sim® version 11.3. A PBPK model was constructed to simulate vancomycin exposure in plasma and CSF. Physicochemical parameters of vancomycin were incorporated into a large molecule model, and tissue distribution was described using the Rodgers-Rowland model.
Results
The final PBPK model incorporated vancomycin’s low brain permeability by adjusting the CSF-to-plasma partition coefficient to 0.17. Model validation was performed using data from 33 patients with ventriculitis under external ventricular drainage. The dosing regimen consisted of a 30 mg/kg loading dose followed by a continuous intravenous infusion of 60 mg/kg/day. Mean simulated vancomycin concentrations in plasma and CSF were 32 mg/L and 7.2 mg/L, respectively. The predicted CSF/plasma concentration ratio was 0.22, which closely matched the observed ratio of 0.17.
Conclusion
Vancomycin penetration into the CNS is low and variable, highlighting the importance of therapeutic drug monitoring and individualized therapy in patients with ventriculitis. In the future, this model may facilitate the selection of optimal dosing regimens by simulating alternative dosing strategies and establishing PK/PD relationships for CNS infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmacometrics (LabFarma), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-902, Brazil.
- Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
- Escola de Medicina, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.
- Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, 01509 010, Brazil.
- Laboratory of Pharmacometrics (LabFarma), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-902, Brazil. fer_unifal@yahoo.com.br.
Förderung
- Universidade Federal Do Rio De Janeiro
Zitieren
APA
Guimarães, L. M. A., de Vasconcellos Nacif, L. O., de Lima Benzi, J. R., de Oliveira Santos, M. T., Yamada, C., Tuon, F. F., Telles, J. P., & de Lima Moreira, F. (2026). Assessment of Vancomycin Penetration into Cerebrospinal Fluid in Patients with Ventriculitis Using a Physiologically Based Pharmacokinetic Approach. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04023-5
Vancouver
Guimarães LMA, de Vasconcellos Nacif LO, de Lima Benzi JR, de Oliveira Santos MT, Yamada C, Tuon FF, et al. Assessment of Vancomycin Penetration into Cerebrospinal Fluid in Patients with Ventriculitis Using a Physiologically Based Pharmacokinetic Approach. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04023-5
BibTeX
@article{Guimares2026,
author = {Guimarães, Larissa Martins Alves and de Vasconcellos Nacif, Letícia Oliveira and de Lima Benzi, Jhohann Richard and de Oliveira Santos, Mayra Torres and Yamada, Carolina and Tuon, Felipe Francisco and Telles, João Paulo and de Lima Moreira, Fernanda},
title = {Assessment of Vancomycin Penetration into Cerebrospinal Fluid in Patients with Ventriculitis Using a Physiologically Based Pharmacokinetic Approach},
journal = {Pharmaceutical Research},
year = {2026},
doi = {10.1007/s11095-026-04023-5}
}
EUVIMED